Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Imaging Dynamics Company Ltd. (IDYLF)
Toronto, ON, CA
Imaging Dynamics Company Ltd. operates as a medical technology firm, supplying digital radiography solutions throughout the Americas and on a global scale. Its product portfolio encompasses a range of imaging detectors, including flat panel models branded as Aquarius 8600 for medical use and VetnovaXion for veterinary applications. Furthermore, the company develops specialized image processing software: Magellan for human medical diagnostics and Sirius for veterinary imaging. Additionally, Imaging Dynamics provides comprehensive digital radiography (DR) systems. These include the 1600 Plus X-Series, an integrated solution featuring a floor-mounted U-arm multi-axis positioning device, complete with an X-ray tube, collimator, and generator. Veterinary-specific DR systems are also part of its offerings. These products are distributed through a robust network comprising independent dealers, value-added distributors, and original equipment manufacturer (OEM) partners. Originally established as Imaging Dynamics Corporation in 1995, the company adopted its current name, Imaging Dynamics Company Ltd., in October 2001. Its corporate headquarters are situated in Toronto, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +152.69% | -21.67% | -97.99% | +38.24% | -99.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+71.0% ★ Q1'26: -89.6% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+60.7% ★ Q1'26: -41.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-531.3% Q1'26: -3,173.2% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-548.6% Q1'26: -3,565.4% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +56.1% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-8.55× Q1'26: -7.95× (vs Q1'25)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiefei Zhang | Chief Financial Officer | 25.0K | female |
| Miaomiao Chen | Chief Financial Officer | 25.0K | female |
| Daniel Tsai | General Counsel | — | male |
| Lei Liu | Group Vice President & Chief Executive Officer of China | — | male |
| Xin Cheng | Corporate Secretary | — | male |
| Yong Yan | Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IDYLF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
